Eisai got favorable injunction for preventing generic version of Aricept


Teva Pharmaceutical is not allowed to start selling generic version of Aricept Anti Alzhimer’s drug. Teva had file PIV ANDA for launching generic version of Eisai’s product Aricept.

According to Bloomberg, Eisai’s biggest product with $2.16 billion in worldwide sales in the year ended in march 2007.

The case is Eisai Co. v. Teva Pharmaceuticals USA Inc., 05cv5727 and 07cv5489, U.S. District Court for the District of New Jersey (Newark).

To read full story: http://www.bloomberg.com/apps/news?pid=20601101&sid=a_oB7QDoTda0&refer=japan

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , , . Bookmark the permalink.

One Response to Eisai got favorable injunction for preventing generic version of Aricept

  1. sandrar says:

    Hi! I was surfing and found your blog post… nice! I love your blog. 🙂 Cheers! Sandra. R.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s